id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0087-0010,FDA,FDA-2009-E-0087,"U.S. Patent & Trademark Office to Pfizer, Inc. - Letter",Other,Letter(s),2012-07-24T04:00:00Z,2012,7,2012-07-24T04:00:00Z,,2012-07-24T19:29:13Z,,0,0,09000064810acf66
FDA-2009-E-0087-0009,FDA,FDA-2009-E-0087,"FDA/CDER to Pfizer, Inc. - Letter",Other,Letter(s),2012-06-04T04:00:00Z,2012,6,2012-06-04T04:00:00Z,,2012-06-04T18:57:32Z,,0,0,0900006481030a30
FDA-2009-E-0087-0008,FDA,FDA-2009-E-0087,"U.S. Patent & Trademark Office to Pfizer, Inc. - Letter",Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-19T16:52:18Z,,0,0,0900006480f90858